Treatment of retinopathy of prematurity

被引:53
|
作者
Clark, David
Mandal, K.
机构
关键词
retinopathy of prematurity; cryotherapy; CRYO-ROP; laser photocoagulation; ETROP;
D O I
10.1016/j.earlhumdev.2007.11.007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Retinopathy of prematurity is a potentially blinding disorder of premature infants. Retinal. ablation of the avascular retina originally described using cryotherapy but now most commonly undertaken with laser photocoagulation, reduces the unfavourable structural outcomes and improves the functional visual acuity outcome. The CRYO-ROP study showed the long-term benefit of treatment of threshold disease compared with no treatment, however even with cryoablation 44.4% of treated eyes had a visual acuity of 6/60 or worse at 10 year follow-up. The ETROP study of earlier treatment for high-risk pre-threshold disease, rather than treatment at threshold, has shown that pre-threshold treatment of type 1 disease produces a significantly improved outcome. Despite treatment some infants develop retinal. detachment for which various surgical treatments have been described, although not always with a good functional outcome. Future treatment modalities may include the use of anti-VEGF therapies. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:95 / 99
页数:5
相关论文
共 50 条
  • [31] UK retinopathy of prematurity treatment survey
    Cuthbertson, F.
    Newsom, R.
    EYE, 2007, 21 (02) : 156 - 157
  • [32] UK retinopathy of prematurity treatment survey
    F Cuthbertson
    R Newsom
    Eye, 2007, 21 : 156 - 157
  • [33] Retinopathy of Prematurity in Triplets
    Sekeroglu, Mehmet Ali
    Hekimoglu, Emre
    Celik, Ulker
    Kale, Yusuf
    Bas, Ahmet Yagmur
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2016, 46 (03): : 114 - 117
  • [34] Screening for retinopathy of prematurity
    O'Keefe, Michael
    Kirwan, Caitriona
    EARLY HUMAN DEVELOPMENT, 2008, 84 (02) : 89 - 94
  • [35] Evidence to date: ranibizumab and its potential in the treatment of retinopathy of prematurity
    Patel, Samir N.
    Klufas, Michael A.
    EYE AND BRAIN, 2019, 11 : 25 - 35
  • [36] Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017
    Trzcionkowska, Kasia
    Vehmeijer, Wouter B. H. J.
    Kerkhoff, Frank T.
    Bauer, Noel J. C.
    Bennebroek, Carlien A. M.
    Dijk, Peter H.
    Dijkman, Koen P.
    van den Dungen, Frank A. M.
    Eggink, Cathrien A.
    Feenstra, Robert P. G.
    Groenendaal, Floris
    van Heijst, Arno F.
    van der Hoeven, Mark A. H. B. M.
    Kornelisse, Rene F.
    Kraal-Biezen, Elke
    Lopriore, Enrico
    Onland, Wes
    de Lavalette, Victor W. Renardel
    van Rijn, Laurentius J.
    Schuerman, Frank A. B. A.
    Simonsz, Huibert J.
    Voskuil-Kerkhof, Elsbeth S. M.
    Witlox, Ruben S. G. M.
    Termote, Jacqueline U. M.
    Schalij-Delfos, Nicoline E.
    ACTA OPHTHALMOLOGICA, 2021, 99 (01) : 97 - 103
  • [37] Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
    Riazi-esfahani, Hamid
    Mahmoudi, Alireza
    Sanatkar, Mehdi
    Farahani, Afsar Dastjani
    Bazvand, Fatemeh
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
  • [39] Combined treatment with laser photocoagulation and cryotherapy for threshold retinopathy of prematurity
    Autrata, R.
    Senkova, K.
    Holousova, M.
    Helmanova, I.
    Pyrochtova, S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2008, 18 (01) : 112 - 117
  • [40] CRYOTHERAPY FOR TREATMENT OF ACTIVE RETINOPATHY OF PREMATURITY - EXPERIENCE IN LONDON, ONTARIO
    BAINS, RA
    CADERA, W
    SIEBERT, L
    HAN, V
    KALAPWRAKAL, M
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 1991, 26 (07): : 358 - 360